Optimizing patient care and research: the Amsterdam Dementia Cohort

Keith A. Johnson, Satoshi Minoshima, Nicolaas I. Bohnen, Kevin J. Donohoe, Norman L. Foster, Peter Herscovitch, Jason H. Karlawish, Christopher C. Rowe, Maria C. Carrillo, Dean M. Hartley, Saima Hedrick, Virginia Pappas, William H. Thies, Appropriate use criteria for amyloid PET: a report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's Association. Alzheimers & Dementia. ,vol. 9, ,(2013) , 10.1016/J.JALZ.2013.01.002

N. Tolboom, M. Yaqub, W. M. van der Flier, R. Boellaard, G. Luurtsema, A. D. Windhorst, F. Barkhof, P. Scheltens, A. A. Lammertsma, B. N.M. van Berckel, Detection of Alzheimer Pathology In Vivo Using Both 11C-PIB and 18F-FDDNP PET The Journal of Nuclear Medicine. ,vol. 50, pp. 191- 197 ,(2009) , 10.2967/JNUMED.108.056499

Bruno Dubois, Howard H Feldman, Claudia Jacova, Steven T DeKosky, Pascale Barberger-Gateau, Jeffrey Cummings, André Delacourte, Douglas Galasko, Serge Gauthier, Gregory Jicha, Kenichi Meguro, John O'Brien, Florence Pasquier, Philippe Robert, Martin Rossor, Steven Salloway, Yaakov Stern, Pieter J Visser, Philip Scheltens, Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria Lancet Neurology. ,vol. 6, pp. 734- 746 ,(2007) , 10.1016/S1474-4422(07)70178-3

Reisa A. Sperling, Clifford R. Jack, Sandra E. Black, Matthew P. Frosch, Steven M. Greenberg, Bradley T. Hyman, Philip Scheltens, Maria C. Carrillo, William Thies, Martin M. Bednar, Ronald S. Black, H. Robert Brashear, Michael Grundman, Eric R. Siemers, Howard H. Feldman, Rachel J. Schindler, Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: recommendations from the Alzheimer's Association Research Roundtable Workgroup. Alzheimers & Dementia. ,vol. 7, pp. 367- 385 ,(2011) , 10.1016/J.JALZ.2011.05.2351

Kaj Blennow, Harald Hampel, CSF markers for incipient Alzheimer's disease Lancet Neurology. ,vol. 2, pp. 605- 613 ,(2003) , 10.1016/S1474-4422(03)00530-1

A. E. van der Vlies, J. D. C. Goos, F. Barkhof, P. Scheltens, W. M. van der Flier, Microbleeds do not affect rate of cognitive decline in Alzheimer disease Neurology. ,vol. 79, pp. 763- 769 ,(2012) , 10.1212/WNL.0B013E3182661F91

H. de Waal, C. J. Stam, M. A. Blankenstein, Y. A. L. Pijnenburg, P. Scheltens, W. M. van der Flier, EEG abnormalities in early and late onset Alzheimer's disease: understanding heterogeneity Journal of Neurology, Neurosurgery, and Psychiatry. ,vol. 82, pp. 67- 71 ,(2011) , 10.1136/JNNP.2010.216432

N. Tolboom, W. M. van der Flier, M. Yaqub, R. Boellaard, N. A. Verwey, M. A. Blankenstein, A. D. Windhorst, P. Scheltens, A. A. Lammertsma, B. N.M. van Berckel, Relationship of Cerebrospinal Fluid Markers to 11C-PiB and 18F-FDDNP Binding The Journal of Nuclear Medicine. ,vol. 50, pp. 1464- 1470 ,(2009) , 10.2967/JNUMED.109.064360

J. L. Cummings, M. Mega, K. Gray, S. Rosenberg-Thompson, D. A. Carusi, J. Gornbein, The Neuropsychiatric Inventory: Comprehensive assessment of psychopathology in dementia Neurology. ,vol. 44, pp. 2308- 2314 ,(1994) , 10.1212/WNL.44.12.2308

Guy M. McKhann, David S. Knopman, Howard Chertkow, Bradley T. Hyman, Clifford R. Jack, Claudia H. Kawas, William E. Klunk, Walter J. Koroshetz, Jennifer J. Manly, Richard Mayeux, Richard C. Mohs, John C. Morris, Martin N. Rossor, Philip Scheltens, Maria C. Carrillo, Bill Thies, Sandra Weintraub, Creighton H. Phelps, The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease Alzheimers & Dementia. ,vol. 7, pp. 263- 269 ,(2011) , 10.1016/J.JALZ.2011.03.005